Louise DeCelis’s History of Diagnosis And Treatments For Triple Negative Breast Cancer

1. Diagnosis date: June 2017 – Stage IIA (cT2N0) triple negative invasive ductal carcinoma of the left breast. 22mm. Ki67 60%
2. Chemo: Started 12 July 2017 – Neo-adjuvant chemotherapy
   1. Three rounds of FEC and three rounds of D (12Jul17 – 24Oct17)
      1. From my memory, the tumour shrunk slightly in the first three rounds but then grew in the next three rounds….
      2. One round (4th) had Carboplatin in it (whilst awaiting results of BRCA testing)
         1. Note: No mutation was detected in ATM, BRCA1, BRCA2, PALB2 or TP53
      3. She had an unplanned admission to hospital with febrile neutropenia after C4
3. Breast surgery: Left skin-sparing mastectomy and sentinel lymph node biopsy on 22 November 2017 – (Prof Andrew Spillane).
   1. Tumour report attached: RCB-III response to treatment with residual 23x20mm grade 3 triple negative invasive ductal carcinoma. No evidence of treatment effect. 1/9 lymph nodes involved with 2.25mm macrometastasis. No ENE or LVI.
4. Radiotherapy: Mid January- 22Feb18: 24 rounds (Dr Marita Morgia)
5. Oral Chemo: Six rounds of Xeloda (capecitabine) (eight were planned) + Zoladex (goserelin) for ovarian suppression
6. Pain in the ribs (for about six weeks) was the catalyst for scans
   1. Abdo USS 30Jul18
   2. CT chest/abdo/pelvis 31Jul18 – report attached
   3. whole body bone scan and Liver MRI 03Aug18
      1. i. Bone Scan – report attached
      2. ii. Liver MRI – report attached

HERE IS A DOCUMENT THAT HAS ALL THE REPORTS THAT WE HAVE IN OUR POSSESSION.

Please see this page that I will continue to update with ongoing treatment.